scholarly journals Inadequate Sensitivity of Laboratory Risk Indicator to Rule Out Necrotizing Fasciitis in the Emergency Department

2016 ◽  
Vol 17 (3) ◽  
pp. 333-336 ◽  
Author(s):  
Elizabeth Burner ◽  
Sean Henderson ◽  
Guenevere Burke ◽  
Jeffrey Nakashioya ◽  
Jerome Hoffman
2017 ◽  
Vol 18 (4) ◽  
pp. 684-689 ◽  
Author(s):  
Michael Neeki ◽  
Fanglong Dong ◽  
Christine Au ◽  
Jake Toy ◽  
Nima Khoshab ◽  
...  

POCUS Journal ◽  
2018 ◽  
Vol 3 (1) ◽  
pp. 13-14
Author(s):  
Hadiel Kaiyasah, MD, MRCS (Glasgow), ABHS-GS ◽  
Maryam Al Ali, MBBS

Soft tissue ultrasound (ST-USS) has been shown to be of utmost importance in assessing patients with soft tissue infections in the emergency department or critical care unit. It aids in guiding the management of soft tissue infection based on the sonographic findings.


2015 ◽  
Vol 15 (Suppl 3) ◽  
pp. s1-s1
Author(s):  
Richard Siau ◽  
Steven Young ◽  
Melissa Blyth ◽  
Kirsty Dickson-Jardine

2021 ◽  
Author(s):  
Reynold Henry ◽  
Kazuhide Matsushima ◽  
Michael Etzel ◽  
Rachel N. Henry ◽  
Adam Golden ◽  
...  

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Anna Slagman ◽  
Julia Searle ◽  
Fabian Holert ◽  
Jörn Ole Vollert ◽  
Reinhold Muller ◽  
...  

Introduction: Mid-regional pro-ANP is mainly synthesized in the atria of the heart and it′s secretion is stimulated by ischemia and distension of the myocardium. Objective: To assess the utility of ANP for rule out NSTEMI in combination with cardiac troponin in unselected patients who attend the Emergency Department (ED) with acute cardiac chief complaints. Methods: Patients with chest pain and dyspnea were enrolled over a period of 30 months in the Emergency Department (n=537). Patients with STEMI were excluded from the analysis as diagnosis is ECG- and not biomarker-based (n=18). Blood samples were drawn within 2 hours after admission. Gold-Standard diagnoses were adjudicated by an independent cardiologist. ANP was measured using the BRAHMS Kryptor MR-proANP assay. The lower limit of detection is 2.1 pmol/l. The 97.5 th percentile of a normal population is 86.2 pmol/l and was applied as a cut-off value in this analysis. Troponin I was measured using the Stratus CS and a cut-off value of 0.1 μg/L was applied. Variables are shown as median (IQR) and 95%-CIs. Results: The median ANP-value in all patients (n=519) was 135 pmol/l. Patients with NSTEMI (n=58) had significantly higher ANP-values (244/104-350 pmol/l) as compared to patients with other diagnoses (126/74-256; p<0.0001). In ROC-analysis ANP had an area under the curve of 0.648 (CI:0.582-0.715) for the diagnosis of NSTEMI. Of all patients, 74.2% were troponin negative at admission (n=385). Of these patients, 32.2% (n=124) were also ANP negative. The prevalence of AMI in this subgroup was 1.6% (n=2). The NPV for the combination of troponin and ANP was 98.4% (CI: 94.3-99.8%) and thus higher than for both markers alone (figure 1). In combination with Copeptin, the NPV increased to 100% (CI: 96.3-100%). Conclusions: ANP has potential for early rule-out of AMI in combination with troponin and, due to a different pathophysiological stimulus, it might be used as part of a triple-marker strategy with copeptin and troponin.


Sign in / Sign up

Export Citation Format

Share Document